RP2,Nivolumab
Replimune,BMS
['rp2 ', 'melanoma']
find mark middleton &amp; kevin harrington in today's poster session at 1:15pm cdt to find out about safety &amp; efficacy results from a phase 1 study of rp2 in patients with #uvealmelanoma: #crukfunded #asco23 
We're here to support our broad cancer research community of 4,000 scientists and clinicians. For general Cancer Research UK news & fundraising follow @CR_UK